Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview

被引:5
|
作者
Kumar, Lalit [1 ]
Kukreti, Gauree [2 ]
Rana, Ritesh [3 ]
Chaurasia, Himanshu [4 ]
Sharma, Anchal [5 ]
Sharma, Neelam [6 ]
Komal [7 ]
机构
[1] GNA Univ, GNA Sch Pharm, Dept Pharmaceut, Phagwara 144401, Punjab, India
[2] Sardar Bhagwan Singh Univ, Sch Pharmaceut Sci & Technol, Dept Pharmaceut, Balawala Dehradun 248161, Uttarakhand, India
[3] Himachal Inst Pharmaceut Educ & Res HIPER, Dept Pharmaceut Sci Pharmaceut, Hamirpur 177033, India
[4] Quantum Univ, Quantum Sch Hlth Sci, Dept Pharm, Vill Mandawar NH73 Roorkee-Dehradun Highway, Roorkee 247662, India
[5] Shiva Inst Pharm, Dept Pharmaceut, Bilaspur 174004, India
[6] Himachal Inst Pharmaceut Educ & Res HIPER, Dept Pharmaceut Sci Pharmacol, Hamirpur 177033, India
[7] Chandigarh Coll Pharm, Dept Pharmacol, Sahibzada Ajit Singh Naga 140307, Punjab, India
关键词
Biodegradable; dosage frequency; nanoparticles; preclinical; PLGA; transdermal; ANTIBACTERIAL ACTIVITY; TOPICAL DELIVERY; IN-VITRO; EX-VIVO; SKIN; SYSTEM; FORMULATION; DESIGN; NANOPRECIPITATION; EMULSIFICATION;
D O I
10.2174/0113816128275385231027054743
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Biodegradable polymeric nanoparticles have garnered pharmaceutical industry attention throughout the past decade. PLGA [Poly(lactic-co-glycolic acid)] is an excellent biodegradable polymer explored for the preparation of nanoparticles that are administered through various routes like intravenous and transdermal. PLGA's versatility makes it a good choice for the preparation of nanoparticles.Objective: The main objective of this review paper was to summarize methods of preparation and characterization of PLGA nanoparticles along with their role in the transdermal delivery of various therapeutic agents.Methods: A literature survey for the present review paper was done using various search engines like Pubmed, Google Scholar, and Science Direct.Results: In comparison to traditional transdermal administration systems, PLGA nanoparticles have demonstrated several benefits in preclinical investigations, including fewer side effects, low dosage frequency, high skin permeability, and simplicity of application.Conclusion: PLGA nanoparticles can be considered efficient nanocarriers for the transdermal delivery of drugs. Nevertheless, the clinical investigation of PLGA nanoparticles for the transdermal administration of therapeutic agents remains a formidable obstacle.
引用
收藏
页码:2940 / 2953
页数:14
相关论文
共 50 条
  • [21] Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
    Long-Bin Cao
    Sha Zeng
    Wei Zhao
    Nanoscale Research Letters, 2016, 11
  • [22] Poly Lactic-co-Glycolic Acid (PLGA) uptake by Candida albicans cells as biodegradable controlled drug delivery carrier
    Kolesova, Olga
    Simonetti, Giovanna
    Donati, Livia
    Pasqua, Gabriella
    Valletta, Alessio
    Chronopoulou, Laura
    Palocci, Cleofe
    MEDICAL MYCOLOGY, 2018, 56 : S154 - S154
  • [23] Correction to: Poly(lactic acid)/poly(lactic-co-glycolic acid)-based microparticles: an overview
    Paolo Blasi
    Journal of Pharmaceutical Investigation, 2019, 49 (6) : 669 - 669
  • [24] Fabrication of poly(sarcosine), poly (ethylene glycol), and poly (lactic-co-glycolic acid) polymeric nanoparticles for cancer drug delivery
    Bhattacharya, Sankha
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 61
  • [25] DEVELOPMENT AND EVALUATION OF MOXIFLOXACIN HYDROCHLORIDE LOADED POLY LACTIC-CO-GLYCOLIC ACID NANOPARTICLES FOR OCULAR DRUG DELIVERY
    Harshal, Mahajan D.
    Rajendra, Wagh D.
    Dheeraj, Baviskar T.
    Hitendra, Mahajan S.
    Bhushan, Mali J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (11): : 5685 - 5693
  • [26] Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery
    Bailey, Brittany A.
    Desai, Kashappa-Goud H.
    Ochyl, Lukasz J.
    Ciotti, Susan M.
    Moon, James J.
    Schwendeman, Steven P.
    MOLECULAR PHARMACEUTICS, 2017, 14 (09) : 3228 - 3237
  • [27] Recent Advances of Poly(lactic-co-glycolic acid)-Based Nanoparticles for Tumor-Targeted Drug Delivery
    Jiang, Linye
    Luo, Jie
    Hong, Dawei
    Guo, Shuhong
    Wang, Shuyi
    Zhou, Bizhong
    Zhou, Shiyu
    Ge, Jingyan
    CHEMISTRYSELECT, 2022, 7 (03):
  • [28] Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis
    Amaral, Andre C.
    Bocca, Anamelia L.
    Ribeiro, Alice M.
    Nunes, Janayna
    Peixoto, Danielle L. G.
    Simioni, Andreza R.
    Primo, Fernando L.
    Lacava, Zulmira G. M.
    Bentes, Ricardo
    Titze-de-Almeida, Ricardo
    Tedesco, Antonio C.
    Morais, Paulo C.
    Felipe, Maria Sueli S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) : 526 - 533
  • [29] Poly (lactic-co-glycolic acid) as a controlled release delivery device
    Tee Yong Lim
    Chye Khoon Poh
    W. Wang
    Journal of Materials Science: Materials in Medicine, 2009, 20 : 1669 - 1675
  • [30] Poly (lactic-co-glycolic acid) as a controlled release delivery device
    Lim, Tee Yong
    Poh, Chye Khoon
    Wang, W.
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2009, 20 (08) : 1669 - 1675